Literature DB >> 9933071

Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate.

M J Curran1, W Bihrle.   

Abstract

We present the case of a hypogonadal patient in whom a 20-fold increase in prostate-specific antigen and a palpable prostatic nodule developed 6 months into the administration of intramuscular testosterone.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9933071     DOI： 10.1016/s0090-4295(98)00348-3

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  22 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  [Therapy of the "aging male"].

Authors:  T Diemer; E W Hauck; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

3.  Relationship between testosterone and erectile dysfunction.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

Review 4.  Differing levels of testosterone and the prostate: a physiological interplay.

Authors:  S Larry Goldenberg; Anthony Koupparis; Michael E Robinson
Journal:  Nat Rev Urol       Date:  2011-05-31       Impact factor: 14.432

Review 5.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

6.  Addressing the pressing issues related to testosterone administration to men with prostate cancer.

Authors:  Alvaro Morales
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

Review 7.  Testosterone therapy and prostate cancer--safety concerns are well founded.

Authors:  Laurence Klotz
Journal:  Nat Rev Urol       Date:  2015-01       Impact factor: 14.432

8.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

Review 9.  Testosterone replacement therapy and prostate cancer: a word of caution.

Authors:  Timothy C Brand; Edith Canby-Hagino; Ian M Thompson
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.